Healthcare & Life Sciences

SPACs in Healthcare & Life Sciences

Download a PDF of this article

SPACs, or special purpose acquisition companies were all the rage in 2020, with the excitement not slowing down during the first quarter of 2021. For private companies looking to go public without pursuing the traditional IPO process, this alternative route to the public markets is more efficient by not requiring a roadshow or book building process, and is less influenced by broader market conditions.1 Although the current market environment is not as frothy compared to peak activity and the enthusiastic frenzy witnessed earlier in the year, intrigue remains high given the expectation of a robust year for the U.S. economy because of the COVID-19 vaccine rollout.

Related Articles

January 21, 2022

FTI Consulting International Trade Bulletin – 21st January

International Trade Bulletin – Eastern promise, home truths: Assessing the prospects for a UK-India Trade Deal

January 21, 2022

FTI Consulting News Bytes – 21st January 2022

Welcome to FTI Consulting News Bytes – a roundup of top tech stories of the week from FTI Consulting’s TMT (Telecom,...

January 21, 2022

FTI Consulting Public Affairs Snapshot: Prêt à Voter? A primer for the French presidential elections

The 2022 electoral calendar promises to deliver box office entertainment for those with an interest in international aff...